Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Gull Laboratories/Fresenius AG

This article was originally published in The Gray Sheet

Executive Summary

Gull Laboratories/Fresenius AG: Gull plans to acquire the diagnostics operations of Germany-based Fresenius Intensive Care and Diagnostics Division in a transaction expected to close in the second quarter of calendar 1997. Consolidation of the two diagnostics businesses is expected to increase Gull's worldwide revenues by 40% and accelerate the anticipated 1997 launch of the Thrombus Precursor Protein (TpP), GeneSTAR program, "and other new infectious disease and autoimmune products," Gull says. For the first nine months of fiscal 1996 (ends Dec. 31), Gull generated $13 mil. in sales. Terms of the deal were not disclosed...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007265

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel